Starpharma Holdings Limited (ASX: SPL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Starpharma Holdings Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Starpharma Holdings Limited (ASX: SPL)
Latest News
Share Market News
Potential ASX winners from government's $1.5bn manufacturing blueprint
Share Market News
Starpharma (ASX:SPL) share price tumbles on oversubscribed placement
Share Fallers
Why a2 Milk, BrainChip, Oil Search, & Starpharma shares are dropping lower
Share Market News
Why Corp Travel Management (ASX:CTD) and Starpharma (ASX:SPL) shares are in trading halts
Share Gainers
Rhinomed (ASX:RNO) share price tries following Starpharma's path to COVID glory
Share Gainers
Starpharma (ASX:SPL) share price jumps on COVID-19 nasal spray update
Share Gainers
Why Althea, BrainChip, Rio Tinto, & Starpharma shares are pushing higher
Share Gainers
Why IOOF, SKYCITY, Starpharma, & Telix shares are storming higher
Share Market News
Starpharma share price jumps 5% on funding for COVID-19 nasal spray
Share Gainers
Why Lendlease, Redbubble, SeaLink, & Starpharma shares are pushing higher
Share Market News
Starpharma share price rockets to record high on DEP remdesivir COVID-19 news
Share Gainers
Starpharma share price rockets to 52-week high on full year update
Frequently Asked Questions
-
No, Starpharma does not pay dividends at this time.
-
Starpharma listed on the ASX on 28 September 2000.
SPL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Starpharma Holdings Limited
Starpharma Holdings Ltd (ASX: SPL) is an Australian biotechnology company involved in the development of dendrimer products for pharmaceutical, life science, and other applications.
Dendrimers are synthetically manufactured, nanoscale molecules, particularly useful to the pharmaceutical industry for their unique properties as carriers of other molecular structures.
Starpharma describes itself as a world leader in the field. The company is developing programs for drug delivery applications, the treatment of respiratory viruses, and its VivaGel product.
VivaGel can be used for the management and prevention of bacterial vaginosis and as a coating for condoms. The company's VIRALEZE product is an antiviral nasal spray approved for use in many countries, including Europe and the UK.
